Insider · CIK 0001754122

Knappertz Volker

Reports to the SEC for 2 companies · CAMBRIDGE, X0

sec.gov

Transactions

Companies

Filings

CIK

0001754122

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-27	AUPHAurinia Pharmaceuticals Inc.S Sale	EVP, Research and Development	SSale	−4,930 sh	$6.10	−$30.1K	319,128
2024-02-20	AUPHAurinia Pharmaceuticals Inc.S Sale	EVP, Research and Development	SSale	−25.1K sh	$5.48	−$138K	324,058
2023-03-02	AUPHAurinia Pharmaceuticals Inc.A Award	EVP, Research and Development	AAward	+191K sh	—	—	344,274
2022-08-01	AUPHAurinia Pharmaceuticals Inc. · Stock Option (right to buy)A Award	EVP, Research and Development	AAward	+257K sh	—	—	256,892
2022-08-01	AUPHAurinia Pharmaceuticals Inc. · Restricted Stock UnitsA Award	EVP, Research and Development	AAward	+153K sh	—	—	152,812
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−12.2K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−8,436 sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−91.6K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−13.7K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−92.4K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−150K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−55.5K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−48.3K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−155K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−93K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−47.8K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−76.5K sh	—	—	0
2021-03-26	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−3,060 sh	$18.10	−$55.4K	92,412
2021-03-01	GW PHARMACEUTICALS PLCShare OptionsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,864 sh	—	—	0
2021-03-01	GW PHARMACEUTICALS PLCF Tax Payment	Chief Medical Officer	FTax Payment	−2,712 sh	$17.85	−$48.4K	95,472
2021-03-01	GW PHARMACEUTICALS PLCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,864 sh	$0.00	+$9.61	98,184
2021-02-26	GW PHARMACEUTICALS PLCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+8,448 sh	$0.00	+$11.827	94,645
2021-02-26	GW PHARMACEUTICALS PLCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+113K sh	$0.00	+$157.567	130,488
2021-02-26	GW PHARMACEUTICALS PLCF Tax Payment	Chief Medical Officer	FTax Payment	−44.3K sh	$17.90	−$793K	86,197
2021-02-26	GW PHARMACEUTICALS PLCShare OptionsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−8,448 sh	—	—	0
2021-02-26	GW PHARMACEUTICALS PLCShare OptionsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−113K sh	—	—	0
2021-02-26	GW PHARMACEUTICALS PLCF Tax Payment	Chief Medical Officer	FTax Payment	−3,325 sh	$17.90	−$59.5K	91,320
2021-02-22	GW PHARMACEUTICALS PLCShare OptionsA Award	Chief Medical Officer	AAward	+47.8K sh	—	—	47,808
2021-02-22	GW PHARMACEUTICALS PLCShare OptionsA Award	Chief Medical Officer	AAward	+76.5K sh	—	—	76,488
2021-01-19	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−6,000 sh	$11.67	−$70K	17,940
2020-11-24	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−12K sh	$10.50	−$126K	23,940
2020-11-11	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−6,000 sh	$10.00	−$60K	35,940
2020-11-04	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−6,000 sh	$9.17	−$55K	41,940
2020-08-04	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−6,000 sh	$11.11	−$66.7K	47,940
2020-07-20	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−6,000 sh	$11.42	−$68.5K	53,940
2020-06-17	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−18K sh	$10.35	−$186K	59,940
2020-06-04	GW PHARMACEUTICALS PLCShare OptionsA Award	Chief Medical Officer	AAward	+155K sh	—	—	155,028
2020-06-04	GW PHARMACEUTICALS PLCShare OptionsA Award	Chief Medical Officer	AAward	+93K sh	—	—	93,024
2020-05-18	GW PHARMACEUTICALS PLCStock OptionsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−12.1K sh	—	—	0
2020-05-18	GW PHARMACEUTICALS PLCStock OptionsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−121K sh	—	—	0
2020-05-18	GW PHARMACEUTICALS PLCF Tax Payment	Chief Medical Officer	FTax Payment	−5,868 sh	$9.67	−$56.7K	86,688
2020-05-18	GW PHARMACEUTICALS PLCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+12.1K sh	$0.00	+$14.573	92,556
2020-05-18	GW PHARMACEUTICALS PLCF Tax Payment	Chief Medical Officer	FTax Payment	−5,868 sh	$9.67	−$56.7K	80,412
2020-05-18	GW PHARMACEUTICALS PLCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+121K sh	$0.00	+$145.771	139,092
2020-03-02	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−3,420 sh	$8.32	−$28.5K	79,392
2020-02-26	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−2,832 sh	$9.17	−$26K	82,992
2020-02-26	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−180 sh	$9.26	−$1,666.8	82,812
2019-05-20	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−6,312 sh	$14.76	−$93.2K	85,824
2019-05-20	GW PHARMACEUTICALS PLCS Sale	Chief Medical Officer	SSale	−5,832 sh	$14.52	−$84.7K	92,136
2019-05-18	GW PHARMACEUTICALS PLCRestricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−12.1K sh	—	—	0

Recent filings

Accepted (ET)
Feb 294
Knappertz Volker0001600620-24-000028
SEC(opens sec.gov)
Feb 224
Knappertz Volker0001600620-24-000022
SEC(opens sec.gov)
Mar 64
Knappertz Volker0001628280-23-006527
SEC(opens sec.gov)
Aug 14
Knappertz Volker0001628280-22-019950
SEC(opens sec.gov)
May 74
Knappertz Volker0000899243-21-018663
SEC(opens sec.gov)
Mar 304
Knappertz Volker0000899243-21-014010
SEC(opens sec.gov)
Mar 24
Knappertz Volker0000899243-21-009218
SEC(opens sec.gov)

Companies

Address

SOVEREIGN HOUSE, VISION PARK, HISTON

CAMBRIDGE, X0, CB24 9BZ